Page 1

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington , D.C. 20549 Form 10 - K Annual report pursuant to Section 13 or 15 ( d ) of the Securities Exchange Act of 1934 for the fiscal year ended December 31 , 2020 OR Transition report pursuant to Section 13 or 15 ( d ) of the Securities Exchange Act of 1934 Delaware ( State or other jurisdiction of incorporation or organization ) Securities registered pursuant to Section 12 ( b ) of the Act : Title of each class Common Stock , par value $ 0.01 per share Commission file number : 001-37576 Surgery Partners , Inc. ( Exact name of registrant as specified in its charter ) 310 Seven Springs Way , Suite 500 Brentwood , Tennessee 37027 ( Address of principal executive offices and zip code ) ( 615 ) 234-5900 ( Registrant's telephone number , including area code ) Large accelerated filer Smaller reporting company Trading Symbol ( s ) SGRY Securities registered pursuant to section 12 ( g ) of the Act : None Name of each exchange on which registered The Nasdaq Global Select Market Indicate by check mark if the registrant is a well - known seasoned issuer , as defined in Rule 405 of the Securities Act . Yes Indicate by check mark if the registrant is not required to file reports pursuant to Section 13 or Section 15 ( d ) of the Act . Yes Indicate by check mark whether the registrant ( 1 ) has filed all reports required to be filed by Section 13 or 15 ( d ) of the Securities Exchange Act of 1934 during the preceding 12 months ( or for such shorter period that the registrant was required to file such reports ) , and ( 2 ) has been subject to such filing requirements for the past 90 days . Yes No 47-3620923 ( I.R.S. Employer Identification No. ) Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S - T ( § 232.405 of this chapter ) during the preceding 12 months ( or for such shorter period that the registrant was required to submit such files ) . Yes - No □ Accelerated filer > Emerging growth company No No Indicate by check mark whether the registrant is a large accelerated filer , an accelerated filer , a non - accelerated filer , a smaller reporting company , or an emerging growth company ( each as defined in Exchange Act Rule 12b - 2 ) . DOCUMENTS INCORPORATED BY REFERENCE Non - accelerated filer If an emerging growth company , indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13 ( a ) of the Exchange Act . Indicate by check mark whether the registrant has filed a report on and attestation to its management's assessment of the effectiveness of its internal control over financial reporting under Section 404 ( b ) of the Sarbanes - Oxley Act ( 15 U.S.C. 7262 ( b ) ) by the registered public accounting firm that prepared or issued its audit report . Indicate by check mark whether the registrant is a shell company ( as defined in Rule 12b - 2 of the Exchange Act ) . Yes No The aggregate market value of the registrant's voting and non - voting common equity held by non - affiliates of the registrant based on the closing price of the shares of common stock on The Nasdaq Stock Market on June 30 , 2020 , was $ 255.9 million . As of March 3 , 2021 , there were 59,859,614 shares of the registrant's common stock outstanding . Portions of the registrant's definitive proxy statement for the 2021 annual meeting of stockholders are incorporated by reference into Part III of this report .